Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €106.36B | 17.6x | 0.46 | €87.52 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €8.53B | 24.1x | -0.51 | €103.70 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.3% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.77B | 19.1x | 0.86 | €333 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.4% Upside | Upgrade to Pro+ | |
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €883.50M | 15x | 2.45 | €75 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | €550.49M | -15.4x | 1.92 | €16.69 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Boiron | Paris | Healthcare | Pharmaceuticals | €415.83M | 36.8x | -0.54 | €24.15 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | €284.73M | -1.7x | -0.06 | €2.99 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | |
DBV Technologies | Paris | Healthcare | Pharmaceuticals | €205.08M | -1.5x | 0.05 | €1.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.3% Upside | Upgrade to Pro+ | |
AB Science | Paris | Healthcare | Pharmaceuticals | €78.14M | -7.8x | -0.28 | €1.17 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advicenne | Paris | Healthcare | Pharmaceuticals | €22.35M | -2.3x | €1.82 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SMAIO | Paris | Healthcare | Pharmaceuticals | €22.05M | -8.9x | 0.02 | €3.88 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aelis Farma | Paris | Healthcare | Pharmaceuticals | €16.45M | -2.3x | 0.05 | €1.21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nicox | Paris | Healthcare | Pharmaceuticals | €16.24M | €0.23 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Valerio Therapeutics | Paris | Healthcare | Pharmaceuticals | €10.19M | -0.6x | -0.02 | €0.07 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |